Amelioration of inflammatory myopathies by glucagon-like peptide-1 receptor agonist via suppressing muscle fibre necroptosis.

Mari KamiyaFumitaka MizoguchiShinsuke Yasuda

Published in: Journal of cachexia, sarcopenia and muscle (2022)

GLP-1R agonist could be a novel therapy for PM that recovers muscle weakness and suppresses muscle inflammation through inhi biting muscle fibre necroptosis.

Keyphrases

skeletal muscle
oxidative stress
signaling pathway
air pollution
heavy metals
risk assessment